Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Concin N; Matias-Guiu X; Fotopoulou C; Creutzberg C; Mutch D; Gaffney D; Lindemann K; Kehoe S; Berek JS

    Response: FIGO staging of endometrial cancer 2023.

    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 164 369-372. .

    [doi:10.1002/ijgo.15277]

  • Albertí-Valls M; Megino-Luque C; Macià A; Gatius S; Matias-Guiu X; Eritja N

    Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.

    Cancers 16 -. .

    [doi:10.3390/cancers16010185]

  • Gatius S; Matias Guiu X; Davidson B

    Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium.

    VIRCHOWS ARCHIV -. .

    [doi:10.1007/s00428-023-03710-7]

  • Ruiz-Mitjana, A; Vidal-Sabanés, M; Navaridas, R; Perramon-Güuell, A; Yeramian, A; Nicholson-Sabate, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X

    Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-ß and p38/ERK MAPK signalling

    BIOMEDICINE & PHARMACOTHERAPY 168 115817-115817. .

    [doi:10.1016/j.biopha.2023.115817]

  • Vergote I; Matias-Guiu X

    New FIGO 2023 endometrial cancer staging validation. Welcome to the first molecular classifiers and new pathological variables!

    EUROPEAN JOURNAL OF CANCER 193 113318-113318. .

    [doi:10.1016/j.ejca.2023.113318]

  • Dorca, E; Velasco, A; Varela, M; Gatius, S; Villatoro, S; Fullana, N; Cuevas, D; Vaquero, M; Birnbaum, A; Neumann, K; Matias-Guiu, X

    Validation of Modaplex POLE mutation assay in endometrial carcinoma

    VIRCHOWS ARCHIV 483 787-794. .

    [doi:10.1007/s00428-023-03636-0]

  • Samain, R; Maiques, O; Monger, J; Lam, H; Candido, J; George, S; Ferrari, N; Kohihammer, L; Lunetto, S; Varela, A; Orgaz, JL; VILARDELL, F; Olsina, JJ; Matias-Guiu, X; Sarker, D; Biddle, A; Balkwill, FR; Eyles, J; Wilkinson, RW; Kocher, HM; Calvo, F; Wells, CM; Sanz-Moreno, V

    CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells

    Science Advances 9 -. .

    [doi:10.1126/sciadv.adi0244]

  • Berek, JS; Matias-Guiu, X; FIGO Endometrial Canc Staging Subcomm; FIGO Womens Canc Comm

    Response: FIGO staging of endometrial cancer: 2023

    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 163 331-331. .

    [doi:10.1002/ijgo.15046]

  • Navaridas, R; Vidal-Sabanés, M; Ruiz-Mitjana, A; Altés, G; Perramon-Güell, A; Yeramian, A; Egea, J; Encinas, M; Gatius, S; Matias-Guiu, X; Dolcet, X

    In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science 10 -. .

    [doi:10.1002/advs.202303134]

  • Berek, JS; Matias-Guiu, X; Creutzberg, C; Fotopoulou, C; Gaffney, D; Kehoe, S; Lindemann, K; Mutch, D; Endometrial Canc Staging Subcomm; FIGO Womens Canc Comm

    FIGO staging of endometrial cancer: 2023

    Journal of Gynecologic Oncology 34 -. .

    [doi:10.3802/jgo.2023.34.e85]

  • Cassier PA; Navaridas R; Bellina M; Rama N; Ducarouge B; Hernandez-Vargas H; Delord JP; Lengrand J; Paradisi A; Fattet L; Garin G; Gheit H; Dalban C; Pastushenko I; Neves D; Jelin R; Gadot N; Braissand N; Léon S; Degletagne C; Matias-Guiu X; Devouassoux-Shisheboran M; Mery-Lamarche E; Allard J; Zindy E; Decaestecker C; Salmon I; Perol D; Dolcet X; Ray-Coquard I; Blanpain C; Bernet A; Mehlen P

    Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.

    Nature 620 409-416. .

    [doi:10.1038/s41586-023-06367-z]

  • Pizarro, D; Romero, I; Perez-Mies, B; Redondo, A; Caniego-Casas, T; Carretero-Barrio, I; Cristobal, E; Gutierrez-Pecharroman, A; Santaballa, A; D'Angelo, E; Hardisson, D; Vieites, B; Matias-Guiu, X; Estevez, P; Guerra, E; Prat, J; Poveda, A; Lopez-Guerrero, JA; Palacios, J

    The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .

    [doi:10.3390/ijms241311183]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares